Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Hand Foot SyndromePalmar Plantar Erythrodysesthesia
Interventions
DRUG

sildenafil citrate

Subjects will be given 2 types of topical creams, one containing 1% sildenafil and one containing placebo control. Subjects will be randomized to apply sildenafil cream to either the right or left hand/foot; placebo cream will be applied to the opposite hand/foot. The cream will be supplied to subjects with proper labeling to indicate right and left application assignment. Cream will be applied to each affected hand/foot two times per day.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER